Marcus & Millichap stock heads into its October 30 earnings report

Published on 10/08/2026 at 05:07 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Marcus & Millichap stock was last at USD 28.22 on October 7, 2026, after Q2 revenue rose 17.8 percent. Two analysts set a Reduce consensus.

MMI, US5663241090, Illustration mit AI erstellt.

Marcus & Millichap, Inc. (ISIN US5663241090) was last at USD 28.22 on the NYSE on October 7, 2026, down 1.33 percent from the prior close. The company is scheduled to publish its Q3 2026 results on October 30, 2026, according to MarketBeat.

Q2 revenue rose 17.8 percent

Marcus & Millichap reported USD 202.91 million in Q2 2026 revenue, up 17.8 percent from USD 172.3 million in Q2 2025. The brokerage also moved from a USD 11.0 million net loss to USD 3.9 million in net income, equal to diluted EPS of USD 0.10, according to Yahoo Finance on September 14, 2026.

The revenue improvement was concentrated in the core brokerage operation. Brokerage commissions increased 18.1 percent to USD 167.0 million, while Private Client Market brokerage revenue rose 13.6 percent to USD 106.2 million in Q2 2026, Yahoo Finance reported.

Profit recovery meets cautious consensus

The earnings comparison was favorable, but the analyst view remains restrained. MarketBeat reported on September 29, 2026, that two analysts supported a Reduce consensus and an average price target of USD 28.00. The target is USD 0.22 below the October 7 price, making the gap a counterweight to the improved quarterly figures.

First-half revenue reached USD 374.4 million, up 18 percent from USD 317.3 million in the first half of 2025. Pretax results also shifted from a USD 17.7 million loss to USD 4.1 million of income, according to Yahoo Finance.

Stock remains below its yearly high

MMI's October 7 range was USD 28.04 to USD 28.48, with volume of 121,087 shares. The 52-week range was USD 24.43 to USD 33.55, while market capitalization stood at USD 1.1 billion on the same date. The price therefore sat USD 5.33 below the yearly high, keeping the recovery in reported operations ahead of the share price.